As of 2024-12-15, the Relative Valuation of Cytokinetics Inc (CYTK) is (109.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 48.65 USD, the upside of Cytokinetics Inc based on Relative Valuation is -324.9%.
The range of the Relative Valuation is (101.20) - (93.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
| Forward P/E multiples | 18.7x - 19.2x | 19.0x |
| Fair Price | (101.20) - (93.88) | (109.41) |
| Upside | -308.0% - -293.0% | -324.9% |
| Date | P/E |
| 2024-12-13 | -9.96 |
| 2024-12-12 | -10.28 |
| 2024-12-11 | -10.38 |
| 2024-12-10 | -10.35 |
| 2024-12-09 | -10.34 |
| 2024-12-06 | -10.43 |
| 2024-12-05 | -10.32 |
| 2024-12-04 | -10.33 |
| 2024-12-03 | -10.55 |
| 2024-12-02 | -10.37 |
| 2024-11-29 | -10.62 |
| 2024-11-27 | -10.69 |
| 2024-11-26 | -10.65 |
| 2024-11-25 | -10.29 |
| 2024-11-22 | -10.05 |
| 2024-11-21 | -9.76 |
| 2024-11-20 | -10.21 |
| 2024-11-19 | -10.46 |
| 2024-11-18 | -10.63 |
| 2024-11-15 | -10.28 |
| 2024-11-14 | -11.20 |
| 2024-11-13 | -11.46 |
| 2024-11-12 | -11.50 |
| 2024-11-11 | -12.00 |
| 2024-11-08 | -11.87 |
| 2024-11-07 | -11.43 |
| 2024-11-06 | -11.36 |
| 2024-11-05 | -10.75 |
| 2024-11-04 | -10.54 |
| 2024-11-01 | -10.61 |
| 2024-10-31 | -10.44 |
| 2024-10-30 | -10.50 |
| 2024-10-29 | -10.55 |
| 2024-10-28 | -10.70 |
| 2024-10-25 | -10.51 |
| 2024-10-24 | -10.73 |
| 2024-10-23 | -10.86 |
| 2024-10-22 | -11.25 |
| 2024-10-21 | -11.02 |
| 2024-10-18 | -11.25 |
| 2024-10-17 | -11.16 |
| 2024-10-16 | -11.32 |
| 2024-10-15 | -11.34 |
| 2024-10-14 | -11.16 |
| 2024-10-11 | -11.24 |
| 2024-10-10 | -10.88 |
| 2024-10-09 | -11.14 |
| 2024-10-08 | -11.12 |
| 2024-10-07 | -11.36 |
| 2024-10-04 | -11.60 |